Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9309565 | 0.90 | AGTR1 (0.59) | AGTR1AGTR2 | |
| SCHEMBL9309107 | 0.90 | AGTR1 (0.59) | AGTR1AGTR2 | |
| SCHEMBL9309120 | 0.89 | AGTR1 (0.59) | AGTR1 | |
| SCHEMBL9309106 | 0.89 | AGTR1 (0.77) | AGTR1AGTR2 | |
| SCHEMBL9859264 | 0.88 | AGTR1 (0.76) | AGTR1AGTR2 | |
| SCHEMBL9859977 | 0.88 | AGTR1 (0.56) | AGTR1AGTR2 | |
| SCHEMBL9309628 | 0.87 | AGTR1 (0.56) | AGTR1AGTR2 | |
| SCHEMBL9310803 | 0.86 | AGTR1 (0.72) | AGTR1AGTR2 | |
| SCHEMBL9309977 | 0.85 | AGTR1 (0.71) | AGTR1AGTR2 | |
| Zolasartan SCHEMBL9311614 | 0.85 | AGTR1 (0.77) | AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5374646-A | Treatment or prophylasix of hypertension and diseases associated with cognitive disorders | GLAXO GROUP LIMITED (GB) | 1994-12-20 | — | — | US | disclosed |
| CN-1052672-A | Benzofuran derivative | GLAXO GROUP LTD (GB) | 1991-07-03 | — | — | CN | disclosed |
| EP-0434249-A2 | Benzofuran derivatives | GLAXO GROUP LIMITED (GB) | 1991-06-26 | — | — | EP | disclosed |